Alliance Pharma PLC Interim Results Analyst Meeting - Change of Time (4851H)
August 18 2016 - 02:00AM
UK Regulatory
TIDMAPH
RNS Number : 4851H
Alliance Pharma PLC
18 August 2016
For immediate release 18 August 2016
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Interim Results Analyst Meeting - Change of Time
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, will hold the analyst presentation of its results for the
six months ended 30 June 2016 at the revised time of 10.30am on
Wednesday 14 September 2016.
The presentation will be held at the offices of Buchanan, 107
Cheapside, London EC2V 6DN. For more information, or to register
attendance, please contact Buchanan on 020 7466 5000.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Andrew Franklin, Chief Financial
Officer
Sarah Robinson, Company Secretary
+ 44 (0) 20 7466
Buchanan 5000
Mark Court / Sophie Cowles
/ Jane Glover
+ 44 (0) 20 7260
Numis Securities Limited 1000
Nominated Adviser: Michael
Meade / Freddie Barnfield
Corporate Broking: James
Black / Toby Adcock
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has sales in more than 100 countries worldwide via direct
sales, joint ventures and a network of distributors. Alliance has a
strong track record of acquiring the rights to established niche
products and it currently owns or licenses the rights to
approximately 90 pharmaceutical and consumer healthcare products.
The Company continues to explore opportunities to expand its
product portfolio.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCKMGMRVNZGVZM
(END) Dow Jones Newswires
August 18, 2016 02:00 ET (06:00 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2023 to Mar 2024